Lubner David Charles is a director of POINT Biopharma Global Inc.
Person profile
Roles
Address
Watertown, Massachusetts
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
POINT Biopharma Global Inc.
27 Dec 23
4
CARGO Therapeutics, Inc.
13 Nov 23
3
CARGO Therapeutics, Inc.
9 Nov 23
4
Arcellx, Inc.
16 Jun 23
4
POINT Biopharma Global Inc.
5 Jun 23
4
Vor Biopharma Inc.
2 Jun 23
4
Dyne Therapeutics, Inc.
25 May 23
4
POINT Biopharma Global Inc.
28 Nov 22
4
Dyne Therapeutics, Inc.
6 Jul 22
4
Vor Biopharma Inc.
16 Jun 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
27 Dec 23 | PNT POINT Biopharma Global | Common Stock | Sale back to company | Dispose D | No | No | 0 | 3,600 | 0.00 | 0 |
27 Dec 23 | PNT POINT Biopharma Global | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 9.12 | 44,749 | 408.11 k | 0 |
27 Dec 23 | PNT POINT Biopharma Global | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 8.31 | 25,614 | 212.85 k | 0 |
27 Dec 23 | PNT POINT Biopharma Global | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 8.47 | 25,000 | 211.75 k | 0 |
26 Dec 23 | PNT POINT Biopharma Global | Common Stock | Dispose U | No | No | 0 | 35,400 | 0.00 | 3,600 | |
9 Nov 23 | CRGX CARGO Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 15 | 25,000 | 375.00 k | 25,000 |
14 Jun 23 | ACLX Arcellx | Stock Option Common Stock | Grant | Acquire A | No | No | 37.94 | 11,459 | 434.75 k | 11,459 |
1 Jun 23 | PNT POINT Biopharma Global | Stock Option Common Stock | Grant | Acquire A | No | No | 9.12 | 44,749 | 408.11 k | 44,749 |